Navigation Links
City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications
Date:5/7/2009

LAKE MARY, Fla., May 7 /PRNewswire-FirstCall/ -- Renewable fuels provider New Generation Biofuels Holdings, Inc. (Nasdaq: NGBF) today announced that it has signed a contract with the City of Baltimore, Maryland,("the City") to provide its renewable biofuel in an evaluation program for boiler applications in the heart of Baltimore. This is the first time the City of Baltimore has evaluated a non fossil fuel in its industrial boilers.

In this program, New Generation Biofuels will sell the City biofuel for evaluation in various city municipal buildings. The outcome of the evaluation is expected to further validate New Generation Biofuels' product as a renewable biofuel which uniquely offers NOx and SO2 reductions as compared to traditional distillate products and provide a platform for the City of Baltimore to expand its RFP definitions to include alternative technology biofuels such as New Generation Biofuels in future tender submissions.

"We are enthusiastic to be working with the City of Baltimore on this evaluation program," said New Generation Biofuels' Chief Executive Officer, Cary Claiborne. "The City of Baltimore understands the importance of a sustainable biofuel to reduce overall greenhouse gas emissions and the importance of using a clean, efficient fuel." Mr. Claiborne continued, "In addition, our biofuel can be used as a 100 percent fuel switch with minimal modification to a customer's equipment."

Department of Public Works (DPW) Energy Advisor Ted Atwood stated, "The Energy Office is constantly looking for new and innovative ways to reduce and save on energy costs in sustainable ways that will benefit our City now and into the future. To that end, I am eager to start the evaluation phase."

About New Generation Biofuels Holdings, Inc.

New Generation Biofuels is a renewable fuels provider. New Generation Biofuels holds an exclusive license for North America, Central America and the Caribbean to commercialize proprietary technology to manufacture alternative biofuels from vegetable oils and animal fats that it markets as a new class of biofuel for power generation, commercial and industrial heating and marine use. The Company believes that its proprietary biofuel can provide a lower cost, renewable alternative energy source with significantly lower emissions than traditional fuels. New Generation Biofuels' business model calls for establishing direct sales from manufacturing plants that it may purchase or build and sublicensing its technology to qualified licensees.

About The City of Baltimore

The City of Baltimore consumes approximately 10 million gallons of fuel oil per year within the City and schools. The Baltimore City Department of Public Works Energy Office is implementing energy efficiency and renewable energy projects at City facilities to reduce energy costs and carbon emissions and to improve air quality. Already in place are energy efficiency measures for buildings, installation of LED lights, and utilization of methane gas from renewable sources. Future projects will include expansion of energy efficiency applications from buildings to water and waste water operations; reduction in use of fossil fuels; and increasing solar and other renewable energy applications. Through reduced purchases of electric power, steam, natural gas, chilled water and reduced maintenance costs the city realizes a savings of $5 million per year.

Forward Looking Statements

This news release contains forward-looking statements. These forward-looking statements concern our operations, prospects, plans, economic performance and financial condition and are based largely on our current beliefs and expectations. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by such forward-looking statements. The risks and uncertainties related to our business include all the risks attendant a development stage business in the volatile energy industry, including, without limitation, the risks set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008.

    Media Contact: Phil Wallis ph: (321) 363-5113
    Or pjwallis@newgenerationbiofuels.com

    IR Contact: Ed Job, CFA ph: (646)213-1914
    Or ed.job@ccgir.com

    Rob Schatz   ph: (212) 370-4500
    Or: Rob@wolfeaxelrod.com

'/>"/>
SOURCE New Generation Biofuels Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
2. Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12
3. New Generation Biofuels Completes Construction of Baltimore Facility
4. Baltimore LASIK Surgeon Roy Chuck, MD, PhD of the Wilmer Eye Institute at Johns Hopkins Lists with Trusted LASIK Surgeons
5. Blake M. Paterson MD, CEO and Co-founder of Alba Therapeutics, Wins Greater Baltimore Committee 2008 Leadership in Bioscience Award
6. Three CEOs and University President Named Winners of Greater Baltimore Committees 2008 Baltimore Region Bioscience Awards
7. Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18
8. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
9. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
10. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
11. MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDoses Electronic Dry Powder Inhaler
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation of AxioMed’s exclusive ... production, company President, Jake Lubinski will be traveling to Switzerland from December 5-10. ... Bern, Lucerne, and Zurich to discuss the benefits of a viscoelastic disc. AxioMed ...
(Date:12/2/2016)... Research and Markets has announced the addition of Jain ... to their offering. ... , An increasing ... anticipated. Nanotechnology will be applied at all stages of drug ... in clinical trials. Many of the assays based on nanobiotechnology ...
(Date:12/2/2016)... York, NY (PRWEB) , ... December 01, 2016 , ... ... event is expanding to three days and will take place on February 1-3, 2017 ... (GSK) and Dr James Gulley (NCI), the program provides a unique 360-degree approach, which ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
Breaking Biology News(10 mins):